University of Thessaly (UTH)
Διαγνωστική και προγνωστική αξία της μέτρησης βιοχημικών δεικτών στον εκπνεόμενο αέρα και στον ορό ασθενών με πρωτοπαθή καρκίνο πνεύμονα
Abstract
dc:descriptionPURPOSE: The aim of the present study was to evaluate the levels of VEGF, 8-isoprostane and TNF-α in EBC and serum of patients with primary lung cancer, in order to evaluate their possible diagnostic and prognostic role. Furthermore, associations between VEGF, 8-isoprostane and TNF-α levels in EBC and serum with clinicopathologic factors were investigated. MATERIAL & METHODS: We enrolled 60 patients with lung cancer (55 male and 5 female, mean age 62.73±0.86 years) and 30 age and gender-matched healthy individuals as controls. EBC and serum were collected before and after chemotherapy. TNF-α, VEGF and 8-isoprostane levels in EBC and serum were analyzed by an immunoenzymatic method (ELISA). RESULTS: A statistically significant difference was observed between lung cancer patients and the control group regarding the values of TNF-α, both in EBC (p<0.0001) and serum (p<0.0004). In addition, levels of VEGF were higher in lung cancer patients than in controls (p<0.0001) so as serum levels (p<0.0001). No differences were observed in 8-isoprostane in EBC between lung cancer patients and controls. In contrast, serum 8-isoprostane levels were higher in lung cancer patients compared to controls (p<0.0001). A statistically significant correlation was also observed between EBC and serum values of 8-isoprostane (p=0.01, r=0.329). None of the biomarkers presented a statistically significant alteration of concentration levels in EBC after the chemotherapy. Nevertheless a statistically significant increase was observed at the levels of serum 8-isoprostane after the chemotherapy (p<0.0001). There was no significant correlation with overall survival for any biomarker in both biological materials. CONCLUSIONS: In conclusion, we have shown that TNF-α, VEGF and 8-isoprostane were detected for the first time in EBC of lung cancer patients. Both in EBC and serum, increased TNF-α and VEGF levels were observed in lung cancer patients, whereas increased levels of 8-isoprostane were observed only in serum. These findings suggest that ΕΒC could provide a simple, non invasive and economic method of monitoring biomarkers in patients with lung cancer. Further longitudinal studies are warranted for the evaluation of the prognostic role of these biomarkers in lung cancer.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Dalaveris, Eleftherios
- Δαλαβέρης, Ελευθέριος
Subjects
dc:subject × 20- Καρκίνος πνεύμονα
- Βιολογικοί δείκτες
- Συμπύκνωμα εκπνεόμενου αέρα
- 8-ισοπροστάνιο
- Παράγοντας νέκρωσης όγκων-α
- Αγγειακός ενδοθηλιακός αυξητικός παράγοντας (VEGF)
- Οξειδωτικό στρες
- Χημειοθεραπεία
- Lung cancer
- Exhaled breath condensate
- 8-isoprostane
- Biomarkers
- TNF-α (Tumors necrosis factor A)
- VEGF ( Vascular endothelium growth factor)
- Oxidative stress
- Chemotherapy
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/23195